Africanews on MSN
South Africa gives twice-yearly HIV prevention jab the green light
It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.
AllAfrica on MSN
South Africa: SA Becomes The First African Country to Register the Twice-a-year Anti-HIV Jab — at Record Speed
South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...
Bizcommunity on MSN
New hope for HIV prevention in South Africa with lenacapavir approval
Lenacapavir is a revolutionary long-acting injectable drug that offers six months of protection with just two annual ...
An HIV prevention jab that provides six months of protection at a time was given the green light by South Africa's medicines regulator. The approval helps to clear the way for a limited public sector ...
South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting ...
By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...
HIV significantly affects sleep, with many affected people living in a state akin to chronic jet lag. A new study with Wits ...
South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...
The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting antiretroviral treatment, as early as March or April 2026.
South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback